RE: iAbra Virolens purportedly chosen after Heathrow test10 Sep 2020 08:16
Heathrow are likely to have chosen the Virolens because of the reported test speed of 20 seconds. Their problem is, as others have indicated, this is an prototype test system. There's no validated system available - no formal clinical trials, no published data on sensitivity and specificity, no approvals and no manufacturing line.
i-Abra's an AI company, that's partnered up with an engineering company (TT Engineering*) - not a biopharma company. Heathrow may want this pushed through but it will still take months for this to get from prototype to approval to market.
*i-Abra isn't a quoted company but TT Engineering is (TTG).
The Virolens